Contract development and manufacturing organization Vetter commenced construction of a 160,000-square-foot clinical manufacture site for aseptic processing in Des Plaines, IL, investing approximately $285 million. The facility will expand Vetter's capabilities for low-volume injectable drug candidates, supporting clinical operations relocation from Skokie. The project promises to enhance U.S. presence and create high-quality jobs, with full operation anticipated by end of 2029.